deoxyepinephrine has been researched along with Uveitis in 3 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study whether topical ibopamine effectively increases the intraocular pressure in patients with ocular hypotony after vitreoretinal surgery, uveitis, or penetrating trauma." | 9.12 | Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. ( Cohen, AC; Ganteris, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC; Veckeneer, M, 2006) |
| "To evaluate the effectiveness of 6 months treatment with ibopamine eye drops in raising the intraocular pressure in patients with therapy-resistant hypotony after vitreoretinal surgery for proliferative vitreoretinopathy secondary to rhegmatogenous retinal detachment or penetrating trauma." | 7.78 | Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma. ( Cohen, AF; Ganteris-Gerritsen, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC, 2012) |
| "Ibopamine 2 % eye drops in combination with topical steroids are a therapeutic option in uveitis-associated ocular hypotony." | 7.73 | [Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine]. ( Iliev, ME; Windisch, BK, 2006) |
| "To study whether topical ibopamine effectively increases the intraocular pressure in patients with ocular hypotony after vitreoretinal surgery, uveitis, or penetrating trauma." | 5.12 | Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. ( Cohen, AC; Ganteris, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC; Veckeneer, M, 2006) |
| "To evaluate the effectiveness of 6 months treatment with ibopamine eye drops in raising the intraocular pressure in patients with therapy-resistant hypotony after vitreoretinal surgery for proliferative vitreoretinopathy secondary to rhegmatogenous retinal detachment or penetrating trauma." | 3.78 | Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma. ( Cohen, AF; Ganteris-Gerritsen, E; Jansen, J; Mulder, PG; Ugahary, LC; van Meurs, JC, 2012) |
| "Ibopamine 2 % eye drops in combination with topical steroids are a therapeutic option in uveitis-associated ocular hypotony." | 3.73 | [Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine]. ( Iliev, ME; Windisch, BK, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganteris-Gerritsen, E | 1 |
| Ugahary, LC | 2 |
| Jansen, J | 2 |
| Mulder, PG | 2 |
| Cohen, AF | 1 |
| van Meurs, JC | 2 |
| Ganteris, E | 1 |
| Veckeneer, M | 1 |
| Cohen, AC | 1 |
| Windisch, BK | 1 |
| Iliev, ME | 1 |
1 trial available for deoxyepinephrine and Uveitis
| Article | Year |
|---|---|
Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma.
Topics: Administration, Topical; Adult; Aged; Chronic Disease; Cross-Over Studies; Deoxyepinephrine; Dopamin | 2006 |
2 other studies available for deoxyepinephrine and Uveitis
| Article | Year |
|---|---|
Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Eye Injuries, | 2012 |
[Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine].
Topics: Administration, Topical; Chronic Disease; Deoxyepinephrine; Humans; Male; Mydriatics; Ocular Hypoten | 2006 |